BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34152626)

  • 1. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.
    Zhou YJ; Gao F; Liu WY; Wong GL; Mahadeva S; Raihan Nik Mustapha N; Wang XD; Chan WK; Wong VW; Zheng MH
    Aliment Pharmacol Ther; 2021 Aug; 54(4):470-480. PubMed ID: 34152626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
    Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
    J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
    Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Yan Y; Xing X; Wang X; Yang L
    Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Spleen Shear Wave Elastography for the Screening of High-risk Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Joseph RC; Devadas K; Varghese J; Oommen TT; Hareendran A; Nahaz N; Narayanan V; George B
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
    Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
    Ismail M
    Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
    Stafylidou M; Paschos P; Katsoula A; Malandris K; Ioakim K; Bekiari E; Haidich AB; Akriviadis E; Tsapas A
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1744-1755.e11. PubMed ID: 31077823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.
    Szakács Z; Erőss B; Soós A; Mátrai P; Szabó I; Pétervári E; Bajor J; Farkas N; Hegyi P; Illés A; Solymár M; Balaskó M; Sarlós P; Szűcs Á; Czimmer J; Vincze Á; Pár G
    Front Physiol; 2019; 10():1028. PubMed ID: 31481896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.